GeneDx Holdings Corp.

GeneDx Holdings Corp. filed an 8-K current report with the SEC on June 18, 2025, under accession number 0001818331-25-000086, carrying the CMLF ticker associated with CM Life Sciences III, the blank-check vehicle sponsored by CM Life Sciences. The SPAC completed its IPO in 2021 targeting the healthcare and life sciences sector. It subsequently combined with Sema4, Inc., which had acquired the GeneDx genomic diagnostics business from OPKO Health, forming the post-merger operating company now active in clinical genomics and whole-genome sequencing, with a focus on pediatric rare disease diagnosis. Sign up at SpacDesk for full filing history, deal analytics, and real-time SPAC intelligence on GeneDx Holdings and thousands of other transactions.